InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（15 笔）
内部人交易记录
董事已披露买入
0
已披露卖出
15
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Wilson Martin, Conseiller Juridique. Officer active across 1 company, notably Rocket Pharmaceuticals, INC.. Aggregated, 21 reports have been recorded. Split: 0 buy · 15 sells. Total volume traded: €382k. History available since 14 February 2024. The latest transaction was filed on 18 August 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Wilson Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
631 股@ US$3.3810.0006% mcap0.5% 占其流量Common StockSEC:0001140361-26-033915:0
3,493 股@ US$3.3810.0031% mcap2.6% 占其流量Common StockSEC:0001140361-26-033413:0
3,361 股@ US$3.6060.0029% mcap50.0% 占其流量Common StockSEC:0001140361-26-021321:0
1,376 股@ US$3.3381.0% 占其流量Common StockSEC:0001140361-26-006317:0
12,253 股@ US$3.3129.2% 占其流量Common StockSEC:0001140361-26-006047:0
311,813 股0Common StockSEC:0001140361-26-005410:0
1,646 股@ US$2.9831.3% 占其流量Common StockSEC:0001140361-25-042854:0
100,000 股0Common StockSEC:0001140361-25-041393:0
150,000 股0Common StockSEC:0001140361-25-034422:0
1,004 股@ US$3.0650.8% 占其流量Common StockSEC:0001140361-25-032090:0
12,109 股@ US$3.0199.7% 占其流量Common StockSEC:0001140361-25-031760:0
587 股@ US$6.4461.1% 占其流量Common StockSEC:0001140361-25-020159:0
946 股@ US$6.5281.8% 占其流量Common StockSEC:0001140361-25-019898:0
3,222 股@ US$10.5810.7% 占其流量Common StockSEC:0001140361-25-005846:0
90,358 股0Common StockSEC:0001140361-25-004297:0
1,175 股@ US$13.0544.8% 占其流量Common StockSEC:0001140361-24-047754:0
1,027 股@ US$18.5045.7% 占其流量Common StockSEC:0001140361-24-037931:0
2,420 股0Common StockSEC:0001140361-24-026873:0
4,100 股@ US$29.33136.5% 占其流量Common StockSEC:0001140361-24-011168:0
3,576 股@ US$29.83832.6% 占其流量Common StockSEC:0001140361-24-008890:0
9,712 股0Common StockSEC:0001140361-24-008360:0
21 条申报中的 21 条
About Wilson Martin
Wilson Martin is Conseiller Juridique and General Counsel at Rocket Pharmaceuticals, INC. The record shows 19 filings in total, and the 19 sampled filings over the period from 2024-02-16 to 2026-05-14 show only sales for a total amount of EUR 369846, with Cession as the modal transaction nature.
